The Latest Cardiac and Vascular News
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the European availability of new innovations in its unique portfolio of solutions that integrate imaging, devices, software, informatics and services at each point in a cardiac patient’s journey at EuroPCR 2021 (May 18-20). During the virtual […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc., a leader in revolutionizing precision heartcare, today announced new data which indicate that the information provided by the HeartFlow FFRct Analysis was a superior predictor of 10-year outcomes compared to the severity of a coronary stenosis shown on a coronary computed tomography angiogram (CTA). The […]
Novel multi-protein blood test data on more than 1,500 patients presented at 2021 American College of Cardiology Scientific Sessions KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc. today announces the presentation of multinational patient data demonstrating its Artificial Intelligence (AI)-driven blood test is more accurate than commonly-used risk factors, genetic tests, and coronary artery calcium […]
DUBLIN, May 18, 2021 /PRNewswire(opens new window)/ — Medtronic plc(opens new window) (NYSE:MDT), the global leader in medical technology, today announced new clinical data from the Global SYMPLICITY Registry (GSR) indicating that renal denervation (RDN) with the Medtronic Symplicity™ Renal Denervation System was associated with clinically significant and sustained blood pressure reductions in a real-world hypertensive […]
IRVINE, Calif.–(BUSINESS WIRE)–Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering from cardiovascular conditions, has announced that encouraging early results for its heart failure clinical trial have been presented. The company has also announced the addition of Stan Rabinovich to […]
MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today reported financial results for the first quarter of 2021 and provided a business update. “Having completed the merger with PHPrecisionMed […]
Study leveraging the IBM® MarketScan® claims database examined bleeding events and rates of surgical procedures in patients initiating P2Y12 inhibitors, FXa inhibitors or dabigatran Analyses revealed that patients receiving P2Y12 inhibitors had a higher burden of significant comorbid conditions at baseline than patients receiving FXa inhibitors or dabigatran Results demonstrate patients prescribed P2Y12 inhibitors […]
PALO ALTO, Calif., May 16, 2021 /PRNewswire/ — ReCor Medical, Inc. (“ReCor”), a wholly-owned subsidiary of Otsuka Medical Devices Co., Ltd., today presented the primary endpoint data from the randomized sham-controlled RADIANCE-HTN TRIO (“TRIO”) study. In subjects with resistant hypertension, those treated with the Paradise™ Ultrasound Renal Denervation System had a greater drop in […]
– Latest-generation TAVI system features advancements to reduce or eliminate risk of blood leakage around valve implant – The non-surgical Navitor TAVI system offers best-in-class deliverability and access through small vessels, expanding treatment options for patients with severe aortic stenosis ABBOTT PARK, Ill., May 17, 2021 /PRNewswire/ — Abbott (NYSE: ABT) today announced it […]
Findings signal need for novel treatment strategies to provide more protection during this high-risk, 90-day period KING OF PRUSSIA, Pa., May 16, 2021 /PRNewswire/ — Global biotherapeutics leader CSL Behring today announced the results of a new meta-analysis of seven interventional Phase 3 clinical trials that included more than 82,000 high-risk patients with […]
